Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The 48 included studies showed consistent evidence linking low maternal 25(OH)D concentrations with increased risk of FGR and SGA, with several analyses demonstrating dose: response patterns at lower vitamin D thresholds.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The role of vitamin D deficiency in fetal growth restriction: a systematic review
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The role of vitamin D deficiency in fetal growth restriction: a systematic review
Systematic review · Frontiers in Medicine · 2026
Original publication title
The role of vitamin D deficiency in fetal growth restriction: a systematic review
Copyright © 2026 Octavia, Nabila, Panjarwanto, Geany, Kosen, Rahman, Yora, Javier, Haekal, Sutanto, Tandayu, Varsha, Putra, Cita, Maharani, Nuruddin, Salsabila and Friska.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To synthesize evidence on the association between maternal 25-hydroxyvitamin D [25(OH)D] concentrations and the risk of FGR and SGA, and to evaluate the impact of vitamin D supplementation on fetal growth outcomes.
Source: ObjectiveAbstract: What methods does the paper describe?
A systematic search of PubMed, Cochrane Library, Springer, ScienceDirect, and DOAJ was performed following PRISMA 2020 guidelines. Observational studies and randomized controlled trials examining maternal vitamin D status and fetal growth outcomes were included.
Source: MethodsAbstract: Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD42024622395.
Source: Systematic review registrationAbstract: Results
The 48 included studies showed consistent evidence linking low maternal 25(OH)D concentrations with increased risk of FGR and SGA, with several analyses demonstrating dose: response patterns at lower vitamin D thresholds. Associations with preterm birth were directionally similar but less consistent. Findings from intervention trials assessing vitamin D supplementation were heterogeneous, influenced by variations in dosage, timing of initiation, baseline vitamin D status, adherence, and co-nutrient exposures. Experimental and mechanistic studies further supported biological plausibility, demonstrating vitamin D: mediated effects on placental angiogenesis, immune modulation, endocrine signaling, and oxidative stress pathways.
Source: ResultsAbstract: Conclusion
Maternal vitamin D deficiency is consistently associated with impaired fetal growth, although findings from supplementation trials remain variable. Standardized dosing strategies, harmonized diagnostic cut-offs, and better-controlled interventions are needed to clarify the optimal role of vitamin D in preventing FGR and SGA.
Source: ConclusionAuthors’ abstract
Background
Fetal Growth Restriction (FGR) and Small-for-Gestational-Age (SGA) are major contributors to perinatal morbidity and mortality. Maternal vitamin D deficiency has been proposed to impair placental development and fetal growth through mechanisms involving angiogenesis, immune regulation, and oxidative stress. Increasing evidence suggests that maternal 25-hydroxyvitamin D [25(OH)D] status may play a significant role in the pathogenesis of impaired fetal growth.
Objective
To synthesize evidence on the association between maternal 25-hydroxyvitamin D [25(OH)D] concentrations and the risk of FGR and SGA, and to evaluate the impact of vitamin D supplementation on fetal growth outcomes.
Methods
A systematic search of PubMed, Cochrane Library, Springer, ScienceDirect, and DOAJ was performed following PRISMA 2020 guidelines. Observational studies and randomized controlled trials examining maternal vitamin D status and fetal growth outcomes were included.
Results
The 48 included studies showed consistent evidence linking low maternal 25(OH)D concentrations with increased risk of FGR and SGA, with several analyses demonstrating dose: response patterns at lower vitamin D thresholds. Associations with preterm birth were directionally similar but less consistent. Findings from intervention trials assessing vitamin D supplementation were heterogeneous, influenced by variations in dosage, timing of initiation, baseline vitamin D status, adherence, and co-nutrient exposures. Experimental and mechanistic studies further supported biological plausibility, demonstrating vitamin D: mediated effects on placental angiogenesis, immune modulation, endocrine signaling, and oxidative stress pathways.
Conclusion
Maternal vitamin D deficiency is consistently associated with impaired fetal growth, although findings from supplementation trials remain variable. Standardized dosing strategies, harmonized diagnostic cut-offs, and better-controlled interventions are needed to clarify the optimal role of vitamin D in preventing FGR and SGA.
Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD42024622395.
Publication and source details
Original title: The role of vitamin D deficiency in fetal growth restriction: a systematic review
Leony Octavia; Putri Nabila; Dwi Andhika Panjarwanto; Putri Lenggo Geany; Yosua Darmadi Kosen; Aldo Aulia Rahman; Vallexa Septina Yora; R. Mohamad Javier; Mohammad Haekal; Lucky Sutanto; Arthur Peter Tandayu; Srigita Varsha; Muhamad Dwi Eka Putra; Angela Anjelina Cita; Brilliant Sofia Maharani; Muhammad Falah Ghani Nuruddin; Savira Salsabila; Dwi Fitri Handayani Friska
Frontiers in Medicine · 2026
* Correspondence: Leony Octavia, leonyoctavias@gmail.comCopyright © 2026 Octavia, Nabila, Panjarwanto, Geany, Kosen, Rahman, Yora, Javier, Haekal, Sutanto, Tandayu, Varsha, Putra, Cita, Maharani, Nuruddin, Salsabila and Friska.2026Octavia, Nabila, Panjarwanto, Geany, Kosen, Rahman, Yora, Javier, Haekal, Sutanto, Tandayu, Varsha, Putra, Cita, Maharani, Nuruddin, Salsabila and Friskahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:22:04.249582+00:00
DOI: 10.3389/fmed.2025.1725177 · PMC12838264